Reference: Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(2S):S1–S239
Reference: Torres VE, Ahn C, Barten TRM, et al. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int. 2025;107(2):234-254. doi:10.1016/j.kint.2024.07.010
The KDIGO 2025 Clinical Practice Guideline (CPG) on ADPKD was reviewed and evaluated by ERKNet experts using the AGREE-II methodology. Following this assessment, the ERKNet Network Board officially endorsed the guideline and committed to implementing its recommendations in clinical practice.
Reference: Müller RU, Messchendorp AL, Birn H, et al. Nephrol Dial Transplant. (2022). doi: 10.1093/ndt/gfab312
Collaboration: ERKNet, ERA, Polycystic Kidney Disease International
Reference: Gimpel C, Bergmann C, Bockenhauer D, et al. Nat Rev Nephrol. (2019). doi: 10.1038/s41581-019-0155-2
Reference: Chapman AB, Devuyst O, Eckardt KU, et al. Kidney Int. (2015). doi: 10.1038/ki.2015.59